PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.38%
Revenue growth under 50% of ADI's 5.87%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
2.44%
Gross profit growth under 50% of ADI's 7.44%. Michael Burry would be concerned about a severe competitive disadvantage.
1.49%
EBIT growth below 50% of ADI's 17.31%. Michael Burry would suspect deeper competitive or cost structure issues.
4.16%
Operating income growth under 50% of ADI's 17.31%. Michael Burry would be concerned about deeper cost or sales issues.
0.83%
Net income growth under 50% of ADI's 19.01%. Michael Burry would suspect the firm is falling well behind a key competitor.
0.96%
EPS growth under 50% of ADI's 19.13%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
0.98%
Diluted EPS growth under 50% of ADI's 18.42%. Michael Burry would worry about an eroding competitive position or excessive dilution.
No Data
No Data available this quarter, please select a different quarter.
-0.11%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
14.47%
Positive OCF growth while ADI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
11.93%
Positive FCF growth while ADI is negative. John Neff would see a strong competitive edge in net cash generation.
66.03%
10Y revenue/share CAGR at 50-75% of ADI's 88.70%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
37.03%
5Y revenue/share CAGR at 50-75% of ADI's 68.59%. Martin Whitman would worry about a lagging mid-term growth trajectory.
14.40%
3Y revenue/share CAGR 1.25-1.5x ADI's 12.70%. Bruce Berkowitz might see better product or regional expansions than the competitor.
164.44%
10Y OCF/share CAGR above 1.5x ADI's 99.35%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
86.38%
5Y OCF/share CAGR at 75-90% of ADI's 106.75%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
21.04%
3Y OCF/share CAGR above 1.5x ADI's 2.28%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
301.53%
Net income/share CAGR above 1.5x ADI's 86.08% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
118.16%
5Y net income/share CAGR 1.25-1.5x ADI's 82.06%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
30.19%
3Y net income/share CAGR 1.25-1.5x ADI's 22.37%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
36.59%
Below 50% of ADI's 168.38%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
28.13%
Below 50% of ADI's 105.13%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
21.31%
3Y equity/share CAGR above 1.5x ADI's 13.84%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
688.88%
10Y dividend/share CAGR above 1.5x ADI's 175.95%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
167.47%
5Y dividend/share CAGR above 1.5x ADI's 64.51%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
64.28%
3Y dividend/share CAGR 1.25-1.5x ADI's 43.37%. Bruce Berkowitz checks if the company's short-term profits or payout policy justify these higher hikes.
3.90%
AR growth well above ADI's 1.11%. Michael Burry fears inflated revenue or higher default risk in the near future.
0.38%
Inventory shrinking or stable vs. ADI's 2.54%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
12.96%
Asset growth above 1.5x ADI's 0.25%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
8.95%
BV/share growth above 1.5x ADI's 0.89%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
23.80%
Debt growth far above ADI's 0.03%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-0.77%
Our R&D shrinks while ADI invests at 1.45%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-3.06%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.